Profil
Anna Gralinska is currently the Head of Corporate Communications at Bio-Rad Laboratories, Inc. She previously worked as the Director of Investor Relations at Mallinckrodt Hospital Products, Inc.
Aktive Positionen von Anna Gralinska
| Unternehmen | Position | Beginn |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Public Communications Contact | 01.04.2022 |
Ehemalige bekannte Positionen von Anna Gralinska
| Unternehmen | Position | Ende |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
